UK Breast Cancer Group is a forum for Clinical and Medical Oncologists

Carlo Palmieri

Professor Carlo Palmieri graduated in anatomy and medicine from the University of London, later obtaining a PhD at Imperial College London.
Carlo Palmieri

Prior to joining The Clatterbridge Cancer Centre, Professor Palmieri held the position of a senior Lecturer within the department of Cancer at Imperial College London and was a Consultant in Medical Oncology at Imperial College Healthcare NHS Trust, and was awarded a prestigious Cancer Research UK Clinician Scientist fellowship. Working as a Medical Oncologist specialising in breast cancer, Professor Palmieri focuses his academic and clinical interests on endocrine therapy breast cancer, and in particular targeting the androgen receptor as well brain metastases secondary to breast cancer.

He is actively involved in developing and initiating translational and clinical research trials and is currently leading a number of studies including focused on brain metastasis including one investigating the use of cell free DNA within cerebrospinal fluid as well as neoadjuvant and real world data studies. He is also currently co-leading CCP-UK CANCER a national NIHR URI funded project which is characterising COVID-19 in cancer patients. Previously, he was the cancer lead for the 100,000 genome project for the North West Coast. He co-chairs the breast group for the Cheshire and Merseyside Cancer Alliance, as co-chairs the National Cancer Research Institute (NCRI) breast group strategic area 2 (Metastatic breast cancer), is a member of the NHS England Genomics Clinical Reference Group and has served as expert cancer member of Department of Health's independent advisory group on use of antibodies/antiviral drugs in patients vulnerable to COVID-19. He is the patient public involvement lead for the Liverpool Experimental Cancer Medicine Centre (ECMC). As a member of Breast International Group brain metastasis working group he is involved in developing studies for brain metastases at international level. He is actively involved in undergraduate teaching and is the speciality lead for oncology for the University to Liverpool Medical School and for postgraduates training leads the National Institute for Health and Care Research (NIHR) Academic Clinical Fellowship (ACF) scheme for Merseyside. He is an advisor to the secondary breast cancer charity ‘Make 2nds Count’.  Alongside this he has co-developed and edited the book, ‘ABC of Cancer Care’ aimed at non-specialists and students, outlining the current management of cancer as well as explaining issues around survivorship and clinical trials. The second edition is currently being developed.